What Is P-21 Peptide?
P-21 is a synthetic peptide mimetic derived from a biologically active region of human ciliary neurotrophic factor (CNTF). The compound is based on a short CNTF-derived peptide sequence.
Chemically, P-21 is reported as Ac-DGGLAG-NH2, with an adamantylated glycine incorporated at the C-terminus. This modification distinguishes P-21 from the corresponding unmodified CNTF-derived peptide sequence.
Research Overview Table
Chemical and Molecular Characteristics
Certificates:
Mechanism of Action Under Investigation
Published research describes P-21 as a competitive inhibitor of leukemia inhibitory factor (LIF) signaling. Experimental studies used reduced STAT3 phosphorylation at Tyr705 as evidence of decreased LIF pathway activity. The precise molecular interaction between P-21 and the LIF receptor remains undefined.
P-21 has also been associated with increased BDNF transcription and expression. Published studies have investigated downstream BDNF/TrkB signaling involving PI3K/Akt, MEK/ERK and PLC/PKC, including increased phosphorylation of GSK3β at Ser9. The complete molecular sequence connecting P-21 to these downstream effects remains uncertain.
Scientific Research Context
P-21 appears in the scientific literature as a CNTF-derived peptide mimetic studied for its neurotrophic and neurogenic properties. Research has examined neurogenesis, neuronal development, synaptic plasticity, and related neurotrophic signaling. The published evidence is derived primarily from in vitro investigations and preclinical animal research, with the compound remaining within the preclinical research stage.
P-21 Biology and Biological Pathways
Primary Biological Function
P-21 has been studied primarily in relation to neurogenesis and neurotrophic biology. Published work examines the generation and maturation of neurons, together with changes in neuronal and synaptic properties. The compound's biological research therefore centers on processes involved in maintaining and developing neuronal networks.
Relevant Metabolic or Signalling Pathways
BDNF-related signaling forms an important part of the P-21 literature. Published P-21 research reports changes in BDNF and pCREB and examines downstream PI3K/Akt, MEK/ERK and PLC/PKC signaling. These pathways provide biochemical endpoints for studying neurotrophic signaling and neuronal plasticity.
Tissue-Specific Biology
P-21 research has focused on the brain, particularly the hippocampus and cerebral cortex. Studies have examined the hippocampal dentate gyrus in relation to neurogenesis, while other investigations have measured synaptic and neurotrophic markers in hippocampal and cortical tissue.
Experimental Biomarkers
Published P-21 studies have measured BDNF, pCREB, GSK3β phosphorylation, synaptophysin, synapsin-1, MAP2 and PSD-95 as biological markers. BDNF and pCREB reflect neurotrophic signaling, while GSK3β phosphorylation provides a measure of signaling activity. Synaptophysin, synapsin-1, MAP2, and PSD-95 provide measures of presynaptic, dendritic, and postsynaptic biology.
Laboratory Investigation Methods
RT-PCR has measured BDNF mRNA in hippocampal tissue, while Western blotting has quantified BDNF and signaling proteins in brain tissue. Immunohistochemistry has identified cellular markers such as DCX and BrdU in defined brain regions. Magnetic resonance spectroscopy has measured metabolites, including myoinositol, in the hippocampus.
Experimental Models Used in Published Research
Published P-21 research has used both in vitro and in vivo experimental models. These models provide different experimental settings for studying the compound, but each has limitations that affect how directly the findings can be interpreted in relation to human biology.
In Vitro Cellular Models
The published literature includes SH-SY5Y cells and SH-CDKL5-KO cells as in vitro models. Their principal limitation is that cultured neuronal cells do not reproduce the cellular diversity, three-dimensional organization, or physiological environment of the intact brain.
Mouse Models
P-21 studies have used C57BL/6 mice, 3xTg-AD mice, Ts65Dn mice, and Cdkl5 knockout mice. These models differ in genetic background and disease-related features. Their common limitation is that mouse biology does not fully reproduce human genetics, brain organization, or disease heterogeneity.
Rat Models
Published work has also included aged rat models. The principal limitation is the species difference between rats and humans. Natural aging in rats also does not capture the full biological complexity and variability of human aging.
Published Scientific Research
Neurogenesis and Synaptic Plasticity
Researchers have investigated P-21 in relation to adult neurogenesis, neuronal maturation, dendritic development, synaptic plasticity and memory processes.
Cognitive Aging
One research area has examined age-related cognitive decline, including the relationship between aging, hippocampal neurogenesis, synaptic plasticity and associated brain changes.
Alzheimer’s Disease
The Alzheimer’s disease literature has investigated amyloid-β pathology, tau pathology, neurodegeneration, neurogenesis, synaptic deficits, and cognitive impairment in relation to P-21.
Down Syndrome
P-21 has also been investigated in Down syndrome, with research addressing developmental delay, hippocampus-dependent memory impairment, synaptic abnormalities, and Alzheimer’s disease-related changes.
CDKL5 Deficiency Disorder
More recent research has examined P-21 in CDKL5 deficiency disorder, focusing on neuronal proliferation, survival, maturation, neuroanatomical abnormalities and associated behavioral changes.
Brain Microstructure
Recent research has investigated brain microstructure and white-matter integrity associated with P-21, using diffusion-based neuroimaging measures to characterize changes in brain tissue structure.
Limitations of Current Research
Evidence Is Predominantly Preclinical
The available P-21 evidence remains predominantly preclinical. This limits the strength of conclusions that can be drawn from the existing literature. Findings from experimental research should therefore be interpreted as preliminary scientific evidence rather than established evidence of effects in humans.
Human Clinical Evidence
Human clinical evidence for P-21 is not established in the available literature. The research base does not provide sufficient controlled human data to determine how findings observed in experimental research translate to human subjects. This remains a major gap in the current evidence base.
Species Differences
Biological differences between species can affect the interpretation of P-21 findings. Differences in neuronal biology, signaling, metabolism and disease processes may influence experimental observations. Consequently, findings from nonhuman research cannot automatically be assumed to reflect the same biological responses in humans.
Study Design Limitations
The available investigations use different experimental conditions, treatment schedules, endpoints, and research designs. These differences make direct comparison across studies more difficult. Variation between experimental approaches can also affect how consistently researchers can interpret individual findings across the broader P-21 literature.
Independent Replication
The P-21 literature remains relatively limited, and independent confirmation across research groups is not extensive. Repeated investigation using independently designed studies would help determine whether reported observations remain consistent across different experimental settings.
Long-Term Evidence
Long-term evidence remains limited. The available literature does not adequately establish the consequences of prolonged P-21 exposure. A recent study specifically identified treatment duration as an unresolved question, indicating that additional research is needed to clarify whether longer exposure produces different findings.
Analytical Documentation
HPLC can assess peptide purity and separate related components. LC-MS can confirm molecular mass and support peptide identity while also helping characterize impurities.
NMR can provide additional structural information when the peptide and analytical conditions allow reliable characterization. Researchers use NMR alongside chromatography and mass spectrometry when they need additional structural evidence.
A Certificate of Analysis (CoA) records the analytical tests and results associated with a specific batch. Analytical documentation helps laboratories verify the material's identity and quality before experimental use. It verifies product identity and quality, not biological performance.
Storage and Laboratory Handling
Store P-21 at 2–8°C, as specified on the Certificate of Analysis. Maintain this storage condition during laboratory storage.
Qualified laboratory personnel should handle P-21 using appropriate laboratory practices and take measures to prevent contamination. Use clean laboratory equipment and maintain suitable laboratory conditions throughout handling. The material is intended for laboratory research use only.
Why Researchers Choose Direct SARMs?
Direct SARMs is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.
Our European-made products undergo rigorous purity testing, and we provide clear product information for each research material. We also aim to provide dependable shipping and a smooth ordering experience.
Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs, we aim to make the research supply process simple, clear and reliable.
Frequently asked questions
Why choose us?
Direct SARMs is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.
Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.
Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs, we aim to make the research supply process simple, clear, and reliable.